Elektrofi Inc
Elektrofi Inc. is a biopharmaceutical delivery technology company dedicated to enhancing the patient experience by enabling self-administration of medications. The company focuses on expanding access to transformative medicines through innovative delivery solutions, supporting clinical development, and providing global support for a diverse portfolio of programs in collaboration with existing and emerging partners.
Leadership & Board
- Current Number of Employees
- 39
- Current LinkedIn Followers
- 9,334
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $112M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $112M
- Latest Funding Round
- Series C
- Post-Money Valuation
- ―
Employee Trend
Elektrofi Inc had 39 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Elektrofi Inc had 9,334 followers as of October 12, 2026. The number of followers increased by 5 (0.05%) week-over-week.
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series C | $112.25M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| General Catalyst | Series C |
| Samsara BioCapital | Series C |
| Marshall Wace | Series C |
| RA Capital Management | Series C |
| Janus Henderson Investors | Series C |
| Eli Lilly and Company | Series C |
| Deep Track Capital | Series C |
| Catalio Capital Management | Series C |
Similar Companies
A snapshot of private companies similar to Elektrofi Inc, helping you discover and navigate related company profiles.
Related News and Analysis
